There is an urgent need for effective vaginal microbicides that women can use to protect themselves against heterosexually-acquired HIV infection. Current clinical trial capacity in sub-Saharan Africa is insufficient to test new microbicides coming through the development pipeline. This three-year project aims at strengthening research capacity for trials of vaginal microbicides in Tanzania and Uganda.